Marker Therapeutics, Inc. (MRKR): Price and Financial Metrics
MRKR Price/Volume Stats
| Current price | $1.14 | 52-week high | $5.99 |
| Prev. close | $1.14 | 52-week low | $0.95 |
| Day low | $1.13 | Volume | 15,670 |
| Day high | $1.17 | Avg. volume | 102,887 |
| 50-day MA | $1.23 | Dividend yield | N/A |
| 200-day MA | $2.63 | Market Cap | 12.90M |
MRKR Stock Price Chart Interactive Chart >
Marker Therapeutics, Inc. (MRKR) Company Bio
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR Price Returns
| 1-mo | 3.64% |
| 3-mo | -32.94% |
| 6-mo | -62.87% |
| 1-year | -71.36% |
| 3-year | -65.39% |
| 5-year | -95.06% |
| YTD | -63.34% |
| 2024 | -43.45% |
| 2023 | 106.84% |
| 2022 | -72.02% |
| 2021 | -34.47% |
| 2020 | -49.65% |
Loading social stream, please wait...